Many countries have entered the second/third waves of COVID-19. Therefore, we need to come up with ways toward uniform strengthening of adaptive immune response to fight...
German researchers found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant...
Data from a real-world study South Africa has indicated that the Omicron variant of COVID-19 is 29% less The post Patients ‘29% less likely to be...
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But medications against Covid-19 have as yet seen only partial success. With...
Molnupiravir – the main component in Merck and Ridgeback Therapeutics’ Covid-19 oral pill – might not be safe for use in pregnant women, according to the...
China Reports First Case Of Omicron As Outbreak Worsens Monday has already been a busy session in terms of new omicron-related news. Not only did the...
Two-dose Covid-19 vaccine regimens do not induce enough neutralizing antibodies against the Omicron coronavirus variant, British scientists found, indicating that increased infections in those previously infected...
One of the ways the Omicron variant is different from other variants is the sheer number of mutations in the spike protein. Does this make it...
It started with two Covid-19 vaccines – 2021 is the year interest in mRNA therapeutics boomed, reports Katrina The post 2021: the year mRNA therapeutics came...
Researchers have identified rare, naturally occurring T cells that can target a protein found in SARS-CoV-2 and other coronaviruses. A component of this protein, a viral...
Last fall, as their Covid-19 vaccine crossed the finish line, Moderna unveiled plans to take its newly proven mRNA platform and use it to effectively change...
Moderna Inc. executives called on investors to wait for more data amid a sharp selloff in the company's shares on Friday, after early data showed its...
FINDINGS Credit: NIAID/NIH FINDINGS Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells...
Knowing when and how often to use rapid tests is key to getting an accurate picture of your COVID-19 status.
Moderna says that it’s on its way to having an mRNA vaccine against not one, but two different seasonal viruses. The biotech released the first early...
Sweden & Germany: No Deaths In Children Due To COVID Authored by Paul Elias Alexander via The Brownstone Institute, The decision by parents to vaccinate their...
Maine Governor Activates National Guard To Help At Hospitals After Mandate Forced Out Hundreds Authored by Zachary Stieber via The Epoch Times, Maine Gov. Janet Mills on...
Careful lab work will complement public health data as researchers worldwide focus on omicron, asking questions about contagiousness, severity of disease and whether vaccines hold up...
AstraZeneca’s antibody cocktail for COVID-19, now called Evushield, has become the first drug in the class to be The post AZ’s antibody first to be cleared...
The U.S. Food and Drug Administration on December 8 authorized the use of AstraZeneca's antibody cocktail to prevent Covid-19 infections in individuals with weak immune systems...
The Omicron variant has been reported in 57 nations and the number of patients needing hospitalization is likely to rise as it spreads, the World Health...
Pfizer and BioNTech say three doses of their Covid-19 vaccine can neutralize the newly discovered Omicron variant of the SARS-CoV-2 virus.
The preliminary data from lab studies shows Pfizer Inc’s (NYSE: PFE) COVID-19 vaccine that it developed in collaboration with Germany’s BioNTech is just as effective against...
Preliminary study results from South Africa have suggested that antibodies stimulated by Pfizer and BioNTech’s Comirnaty are less The post Omicron may evade Pfizer/BioNTech COVID jab,...
The World Health Organization updated its guidelines for COVID-19 treatments against the use of convalescent plasma for all cases of infection.
Pfizer Vaccine Less Effective Against Omicron Than Beta Variant, South Africa Study Reveals Earlier this afternoon we wondered what time the traditional late day selloff would...
While markets are cautiously optimistic on the Omicron variant, these health care stocks are still hard at work. The post Good Stocks To Invest In Right...
Future pandemics could be even more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it...
The World Health Organization said late today that it’s not recommending the use of convalescent plasma as a treatment for Covid-19 for mild or severe cases,...
It is now widely known that COVID-19 is associated with the transient or long-term loss of olfaction (the sense of smell) but the mechanisms remain obscure....